The Library

Treatment & Research reports

121 reports, newest first · page 1 of 5

2026

  1. Oral Alintegimod (7HP349) Trial Adds Mesothelioma to Its Cohorts
  2. Italian Imaging-Meso Study Maps the Mesothelioma Immune Map
  3. MDNA11 IL-2 Superkine Trial Includes Pleural Mesothelioma
  4. Rina-S Trial Adds Mesothelioma to Its Tumor Cohorts
  5. TNG462 Trial: PRMT5 Inhibitor for MTAP-Deleted Mesothelioma
  6. STEALTH-001 Trial Tests VET3-TGI Oncolytic Virus in Solid Tumors
  7. VT3989 TEAD Inhibitor Trial Opens to Mesothelioma Patients
  8. NCI Registry Tracks 1,000 Mesothelioma Patients and Families With BAP1 Mutations (NCT03830229)
  9. Former South African Asbestos Miners Face Higher Mortality, UCT Study Finds
  10. 3D Mesothelioma Spheroids Reveal Why Chemo Often Fails
  11. Mesothelioma Prognosis: ECOG Score Spans 4 to 14 Months
  12. HIPEC and Cytoreductive Surgery for Peritoneal Mesothelioma: Who Qualifies and What to Expect
  13. How to Find and Join a Mesothelioma Trial
  14. First-Line Mesothelioma Treatment: 18.1 vs. 14.1 Months
  15. Second-Line Mesothelioma Treatment: When First-Line Stops Working, What Comes Next
  16. Mesothelioma Survival Rates by Stage and Histology: What the Trial Data Actually Show
  17. Pleurectomy/Decortication vs Extrapleural Pneumonectomy: How Mesothelioma Surgery Decisions Are Made
  18. Stage 1 Pleural Mesothelioma: Operable Disease and the Multimodal Treatment Window
  19. Stage 2 Pleural Mesothelioma: Borderline-Operable Disease and the Induction-Therapy Decision
  20. Stage 3 Pleural Mesothelioma: Inoperable Disease, Immunotherapy, and the Active Trial Landscape
  21. Mesothelioma Chest Pain: How It Differs from Cardiac, Pleural, and Muscular Causes
  22. Mesothelioma Early Warning Signs: What to Notice 20 to 50 Years After Asbestos Exposure
  23. The Mesothelioma Symptom Timeline: From Latency to Late-Stage Progression
  24. Pleural Effusion in Mesothelioma: Drainage, Recurrence, and What It Means for Prognosis
  25. Stage 4 Mesothelioma: What to Expect and How Late-Stage Symptoms Are Managed
  26. Two Chemo-Combo Trials, Two Very Different Signals
  27. FDA Grants Orphan Drug Status to Orion's ODM-212
  28. V Foundation Awards $1 Million Grant to UH Cancer Center for BAP1 Mesothelioma Research
  29. Louisiana Mesothelioma by the Numbers: Avondale, Refineries, and a One Year Deadline
  30. New Jersey Mesothelioma by the Numbers: Shipyards, Refineries, and a Century of Exposure